At QuantBioMed, we are building a 3-tier AI-enabled platform to future-proof pre-clinical and early-stage clinical discoveries, ensuring they swiftly advance beyond Phase 1 Clinical Trials. By intelligently harnessing massive clinical resources, we are paving the way for AI-driven Precision Medicine.
By seamlessly integrating AI, real-world data, and cutting-edge computational biology, we are transforming the landscape of biomarker discovery— accelerating the transition from discovery to clinical impact. Our approach starts with identifying the research gaps in clinical care, followed by AI-based insights generation using big biomedical data and subsequent validation in real-world datasets obtained through our clinician-patient networks.
Harnessing big multi-omics data for rapid insights.
Confirming in-silico discoveries using real-world clinical data.
Accelerating translational success with cost-efficient strategies.
Emerging research reveals novel subtypes within Type 2 Diabetes Mellitus (T2DM), influencing disease progression and treatment responses, overlooked by traditional classifications.
Building on this research, we are developing easy-to-use biomarkers to accurately identify T2DM subtypes, enabling precise and personalized treatment strategies.
Read MoreMachine learning reveals key immune-modulating cell subsets in cancer playing critical roles in dictating anti-tumour responses in solid cancers.
By analyzing the complex cellular interactions within the tumour microenvironment, we are identifying previously uncharacterized cell populations influencing immune activity and therapeutic outcomes.
Read MoreMulti-omics research identifies novel circulatory markers of adipose aging, enhancing metabolic health assessments.
Using multi-omics analysis followed by clinical and population-level validation in over 1000 samples and adipose tissues, we have discovered novel biomarkers that mark adipose ageing and metabolic dysfunction in the Indian population.
Read More10 Regal Walk
Bexleyheath
London DA6 7BP
United Kingdom
For collaborations & futher information reach out to [email protected]